Genomic Study for the Prediction of Efficacy and Adverse Effects of CD11a Monoclonal Antibodies(Raptiva)

计划入组 20 人 · 首次发布于 2008 年 1 月 28 日

Role of CD11a in Pathogenesis of Primary ITP and Effect of Immunosuppressive Therapy on Its Level

计划入组 80 人 · 首次发布于 2019 年 3 月 6 日

A Study of Efalizumab in Participants With Moderate to Severe Chronic Psoriasis Who Have Failed, Have a Contraindication to, or Are Intolerant of Other Systemic Therapies

计划入组 1,266 人 · 首次发布于 2005 年 11 月 7 日

Efalizumab

CD16A(AI Proteins)

targeting CD117 HSPC therapy (Cimeio)

Cellenkos Receives FDA Fast Track Designation for CK0803 in Amyotrophic Lateral Sclerosis

Cellenkos' Novel Off-The-Shelf Treg Cell Therapy Demonstrates Promising Results in ALS Clinical Study

Jasper Therapeutics Advances Stem Cell Conditioning with JSP191 and CD117-Targeted Therapies